Global Endowment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-28,040
Closed -$4.11M 233
2019
Q1
$4.11M Buy
28,040
+24,400
+670% +$3.54M 0.58% 33
2018
Q4
$487K Sell
3,640
-31,300
-90% -$5.13M 0.1% 95
2018
Q3
$6.66M Sell
34,940
-2,100
-6% -$386K 0.88% 25
2018
Q2
$6.17M Buy
37,040
+11,200
+43% +$1.8M 0.81% 32
2018
Q1
$4.35M Buy
25,840
+4,700
+22% +$788K 0.63% 24
2017
Q4
$3.46M Buy
21,140
+5,600
+36% +$1M 0.5% 42
2017
Q3
$3.19M Buy
15,540
+1,900
+14% +$442K 0.45% 48
2017
Q2
$3.32M Buy
13,640
+600
+5% +$141K 0.45% 35
2017
Q1
$3.12M Sell
13,040
-900
-6% -$210K 0.45% 34
2016
Q4
$2.93M Sell
13,940
-800
-5% -$166K 0.45% 26
2016
Q3
$3.4M Buy
+14,740
New +$3.6M 0.56% 41

Other funds holding AGN

Global Endowment Management's AGN Position: Q2 2019 in Review

Global Endowment Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 28,040 shares — an estimated $4.11M sold.

Global Endowment Management first reported a position in AGN in Q3 2016 and held it in 11 quarters. The position peaked at $6.66M in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Global Endowment Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Global Endowment Management sold 28,040 Allergan plc shares in Q2 2019, an estimated $4.11M.
  • Global Endowment Management first reported a position in Allergan plc in Q3 2016 and held it in 11 quarters.
  • Global Endowment Management's Allergan plc position peaked at $6.66M in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Global Endowment Management's 13F filing for Q2 2019, filed 12 Aug 2019.